Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2015 3
2016 2
2017 2
2018 2
2019 4
2020 4
2021 4
2022 8
2023 9
2024 3
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective study.
Massaro M, Comito T, Franzese C, Teriaca MA, Loi M, Badalamenti M, Franceschini D, Ilieva MB, Marini B, Lo Faro L, Vernier V, Tomatis S, Gallo P, Bozzarelli S, Rimassa L, Bonifacio C, Carrara S, Capretti GL, Santoro A, Zerbi A, Scorsetti M. Massaro M, et al. Among authors: bozzarelli s. Radiat Oncol. 2026 May 13;21(1):84. doi: 10.1186/s13014-026-02848-3. Radiat Oncol. 2026. PMID: 42129843 Free PMC article.
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Camera S, Fornaro L, Rimini M, Persano M, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Salani F, Bozzarelli S, Corallo S, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Chiara P, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Melo Alvim C, Roque R, Farinea G, Genovesi V, De Rosa A, Lavacchi D, Lo Prinzi F, Passeri L, Ferrara M, Foti S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Tesini G, Esposito L, Casadio C, Himmelsbach V, Landriscina M, Ahcene Djaballah S, Bekaii-Saab T, Masi G, Vogel A, Lonardi S, Vivaldi C, Rimassa L, Casadei-Gardini A. Camera S, et al. Among authors: bozzarelli s. Target Oncol. 2026 Mar;21(2):237-253. doi: 10.1007/s11523-026-01200-9. Epub 2026 Feb 27. Target Oncol. 2026. PMID: 41758293
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.
Pircher C, Nichetti F, Rizzato MD, Bensi M, Salani F, Balsano R, Rota S, Sciortino C, Paolo GD, Trovato G, Genovesi V, Bozzarelli S, Busset MDD, Marchesi S, Gusmaroli E, Mazzaferro V, Salvatore L, Vivaldi C, Sperotto S, Rimassa L, de Braud F, Pietrantonio F, Lonardi S, Niger M. Pircher C, et al. Among authors: bozzarelli s. Liver Int. 2026 Feb;46(2):e70502. doi: 10.1111/liv.70502. Liver Int. 2026. PMID: 41467999
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.
Sciortino C, Nichetti F, Bergamo F, Palermo F, Tamberi S, Vivaldi C, Ongaro E, Arcangeli G, Marchesi S, Giommoni E, Cella CA, Pircher C, Chiaramonte A, Bencardino K, Sottotetti E, Martinetti A, Rapposelli IG, Corallo S, Di Donato S, Murialdo R, Delliponti L, Salvatore L, Bozzarelli S, Dell'Aquila E, Miceli R, Carnaghi C, Tomasello G, Rivizzigno P, Bonomi M, Mannavola F, Forti L, Garajovà I, Attademo L, Galassi B, Chiari R, Leone F, Garattini SK, Tamburini E, Pietrantonio F, Niger M. Sciortino C, et al. Among authors: bozzarelli s. Dig Liver Dis. 2025 Dec;57(12):2470-2477. doi: 10.1016/j.dld.2025.11.007. Epub 2025 Nov 28. Dig Liver Dis. 2025. PMID: 41318310 Free article.
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.
Reni M, Macchini M, Orsi G, Procaccio L, Malleo G, Carconi C, Rapposelli IG, Bencardino K, Scartozzi M, Balzano G, Tamburrino D, Merelli B, Sperti E, Belfiori G, Liscia N, Bozzarelli S, Di Marco M, Tamburini E, Milella M, Lonardi S, Ercolani G, Mazzola M, Palumbo D, Torri V, Falconi M. Reni M, et al. Among authors: bozzarelli s. Lancet. 2026 Dec 20;406(10522):2945-2956. doi: 10.1016/S0140-6736(25)01685-X. Epub 2025 Nov 20. Lancet. 2026. PMID: 41275879 Clinical Trial.
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.
Rimini M, Fornaro L, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Lamarca A, Landriscina M, Fimkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Pinto CMS, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan S, Warmington E, Lancianese A, Bekaii-Saab T, Lavacchi D, Kang M, Lonardi S, Vogel A, Prete AA, Bozzarelli S, Salani F, Persano M, Masi G, Balsano R, Niger M, Camera S, Passeri L, Ferrara M, Satake T, Rimassa L, Casadei-Gardini A. Rimini M, et al. Among authors: bozzarelli s. Liver Int. 2025 Dec;45(12):e70428. doi: 10.1111/liv.70428. Liver Int. 2025. PMID: 41221651 Free PMC article.
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis.
Ghidini M, Petrelli F, Paccagnella M, Salati M, Bergamo F, Ratti M, Soldà C, Galassi B, Garrone O, Rovatti M, Zefelippo A, Caccamo L, Gringeri E, Zerbi A, Torzilli G, Bozzarelli S, Rimassa L, Tomasello G. Ghidini M, et al. Among authors: bozzarelli s. Cancers (Basel). 2025 Jul 23;17(15):2445. doi: 10.3390/cancers17152445. Cancers (Basel). 2025. PMID: 40805148 Free PMC article.
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.
Milella M, Orsi G, di Marco M, Salvatore L, Procaccio L, Noventa S, Bozzarelli S, Garajova I, Vasile E, Giordano G, Macchini M, Cavaliere A, Gaule M, Bergamo F, Chiaravalli M, Palloni A, Carloni R, Bittoni A, Niger M, Rapposelli IG, Rodriquenz MG, Scartozzi M, Mosconi S, Giommoni E, Bernardini I, Paratore C, Spallanzani A, Bencardino K, Forti L, Tamburini E, Lonardi S, Scarpa A, Cascinu S, Tortora G, Sperduti I, Reni M. Milella M, et al. Among authors: bozzarelli s. Cancer Med. 2025 Feb;14(3):e70364. doi: 10.1002/cam4.70364. Cancer Med. 2025. PMID: 39861955 Free PMC article.
49 results